Pancreatic cancer is the toughest of cancer challenges. It’s tough to diagnose, tough to treat, tough to research and tough to survive. But we’re taking it on.
Our vision is that everyone with pancreatic cancer survives to live long and well.
We’ll transform the future for pancreatic cancer by funding research breakthroughs, campaigning for changes to treatment and care and supporting people when they need it the most.
Our five-year strategy: Finding breakthroughs. Giving hope. Saving lives.
In the last five years we have seen more progress than in the previous five decades. In the next five years, we know we can step up the pace and drive this progress even further forward, transforming how we diagnose, treat and care for people with pancreatic cancer – and ultimately saving lives.
The scale of this challenge needs a united approach - I hope that you will join us to bring about the transformation in survival rates that we dream of. The time to act is now.
Our research strategy
Our research strategy sets out our ambition to ensure that the next five years see the transformational advances in pancreatic cancer research that have been sorely lacking over the last 50 years.
Pancreatic Cancer UK is a registered charity in England & Wales (1112708) and Scotland (SC046392). Read more about us and our charity status on the Charity Commission website.
Latest news
5 February 2026
New combination of drugs shown to effectively treat pancreatic cancer in mice
Our Head of Research, Dr Madina Kara, comments on the recent news that scientists from the Spanish National Research Centre have been able to eliminat...
4 February 2026
Our response to the National Cancer Plan for England
Today, Secretary of State for Health and Social Care, Wes Streeting revealed the eagerly awaited National Cancer Plan for England. Our CEO, Diana Jupp...
26 January 2026
Rare Cancers Bill passes Second Reading
Earlier this month – fittingly, during Less Survivable Cancers Week – our team were delighted to be in the House of Lords to watch the Rare Cancers Bi...
5 February 2026
New combination of drugs shown to effectively treat pancreatic cancer in mice
Our Head of Research, Dr Madina Kara, comments on the recent news that scientists from the Spanish National Research Centre have been able to eliminat...
Read more4 February 2026
Our response to the National Cancer Plan for England
Today, Secretary of State for Health and Social Care, Wes Streeting revealed the eagerly awaited National Cancer Plan for England. Our CEO, Diana Jupp...
Read more26 January 2026
Rare Cancers Bill passes Second Reading
Earlier this month – fittingly, during Less Survivable Cancers Week – our team were delighted to be in the House of Lords to watch the Rare Cancers Bi...
Read more